For example, miR‐26 mimics reverse MYC‐driven suppression to induce tumor regression in HCC [384]; lipid nanoparticles (LNP)‐delivered miR‐34a suppresses CD44+ stem‐like cell populations and metastasis in PCa [385]; and intratumoral delivery of the miR‐15a/16 cluster inhibits tumor progression in prostate models [386]. The gene discussed is MYC; the disease is hepatocellular carcinoma.